Work

RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease

Year: 2023

Type: article

Source: Expert Opinion on Investigational Drugs

DOI: 10.1080/13543784.2023.2239707

Authors: Pavel Strnad, Javier San Martin

Institutions: Universitätsklinikum Aachen, RWTH Aachen University, Arrowhead Pharmaceuticals (United States)

Language: English

Topic: RNA Interference and Gene Delivery

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4384820732

FWCI: 0.67

Cites: 54

Cited by: 9

Related to: 10